Adam Le

Side Letter: Lazard CL launches

Is Lazard CL the industry's new private capital advisory behemoth?

Hamilton Lane's Hirsch: Private markets industry has too many GPs

A surplus of managers is diluting talent pools and creating fundraising challenges, says Erik Hirsch, executive co-chairman, in the latest episode of PEI's Spotlight podcast.

Alaska Permanent writes down value of 46 alternatives funds

The number of private equity, private credit and infrastructure vehicles deemed 'impaired' by the SWF has risen 35% year-on-year.

The thorny issue of LP incentivisation

Bonus structures vary wildly among private equity's biggest LPs.

Mubadala: Healthcare PE's real test is patients, not just returns

The sovereign fund can write tickets up to $2bn per transaction, Josh Zhou, head of healthcare private equity for North America, tells PEI.

The ‘open survival ending’ is where most zombie funds are likely headed

Until the PE exit environment improves, (unnaturally) long life funds will continue to multiply.

Our mid-year take on the market’s hottest topics

Here’s how six key areas of private equity market have developed so far this year, and what might happen next.

Ex-APG PE veteran on how pensions can better assess performance

Internal asset class evaluations and specific goal assessments are key when looking at performance, John Renkema, who spent more than two decades at the Dutch pension giant, tells PEI.

Sweden's Alecta: Purchase multiples are the new DPI

Disciplined entry pricing links directly to value creation, Jonas Nyquist, head of alternatives at the €126.7bn pension, tells PEI.

When stratospheric net worth meets LP-GP alignment

What happens to incentivisation structures when a potential carry payout represents a mere drop in the ocean of an investment executive's net worth?